Purpose
To develop and advance innovative self-amplifying RNA malaria vaccines that improve protection, reduce costs, and expand equitable access for people in low- and middle-income countries.
Grantee
Division
Global Health
Date
NOVEMBER 2025
Region served
GLOBAL
Committed amount
$2,881,799
Grant topic
Vaccine Development
Duration (months)
21
Grantee location
Gaithersburg, Maryland, United States
Related work
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.